These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5188497)

  • 1. [Clinical use of inosine in patients treated by irradiation].
    Kamata R; Haruyama K; Okano J; Maruyama M
    Rinsho Hoshasen; 1968 May; 13(5):328-33. PubMed ID: 5188497
    [No Abstract]   [Full Text] [Related]  

  • 2. [The synthesis of inosinic acid, inosine and hypoxanthine in the pigeon liver at periods immediately after irradiation and injection of radiation-protective agents].
    Romantsev EF; Khalikov SK
    Radiobiologiia; 1966; 6(2):268-71. PubMed ID: 6000529
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Inosine on radiation damage, especially on leukopenia].
    Moriyama T; Takaki H; Mizukami T; Aoki T; Noguchi S
    Igaku Kenkyu; 1966 Dec; 36(6):698-702. PubMed ID: 6010016
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of nucleosides on the contractile function of the myocardium in the emergency stage of compensatory function of the heart].
    Meerson FZ; Buckley NM; Kapel'ko VI; Shenderov SM
    Biull Eksp Biol Med; 1966 Apr; 61(4):16-8. PubMed ID: 6005299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer trends: the potential of radiation modifiers.
    Elkon D
    Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of radiation therapy in the curative treatment of metastatic disease.
    Peters LJ; Milas L; Fletcher GH
    Symp Fundam Cancer Res; 1983; 36():411-20. PubMed ID: 6382517
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical radiation sensitizers and protectors: recent developments.
    Kim JH; Chu FC
    Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335
    [No Abstract]   [Full Text] [Related]  

  • 9. Amifostine and radiation therapy: past, present, and future.
    Tannehill SP; Mehta MP
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation modifiers: treatment overview and future investigations.
    Thomas CT; Ammar A; Farrell JJ; Elsaleh H
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants and chemotherapy.
    Galland L
    Altern Ther Health Med; 2007; 13(5):13. PubMed ID: 17900036
    [No Abstract]   [Full Text] [Related]  

  • 13. Azelastine: its clinical application for radiation dermatitis.
    Furusawa M; Baba Y; Murakami R; Yokoyama T; Uozumi H; Nishimura R; Takada C; Takahashi M; Eura M; Ishikawa T
    Radiat Med; 1996; 14(3):151-4. PubMed ID: 8827810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of Tathion in radiotherapy].
    Kakishita M; Rikimaru S; Oba S; Muramoto T; Fukui K
    Rinsho Hoshasen; 1972 May; 17(5):336-40. PubMed ID: 4483827
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoprotection for radiation-associated normal tissue injury.
    Mao J; Fatunase OA; Marks LB
    Cancer Treat Res; 2008; 139():307-27. PubMed ID: 18236722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation with a new radioprotective compound (methyl-methionine-sulfone chloride)].
    De Vecchi A
    Radiobiol Radioter Fis Med; 1967; 22(5):355-70. PubMed ID: 5608263
    [No Abstract]   [Full Text] [Related]  

  • 17. A new administration schedule for amifostine as a radioprotector in cancer therapy.
    Wagner W; Radmard A; Schönekaes KG
    Anticancer Res; 1999; 19(3B):2281-3. PubMed ID: 10472344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic approaches to radiation protection.
    Brizel DM
    J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pentoxifylline as a modifier of radiation therapy.
    Nieder C; Zimmermann FB; Adam M; Molls M
    Cancer Treat Rev; 2005 Oct; 31(6):448-55. PubMed ID: 16225996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteration of radiation-induced hematotoxicity by amifostine (ethyol)].
    Momm F; Bechtold C; Fischer K; Tsekos A; Henke M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():2-5. PubMed ID: 10584132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.